EMEA-001171-PIP01-11-M02
Key facts
| Invented name |
Cardioplexol
|
| Active substance |
|
| Therapeutic area |
Other
|
| Decision number |
P/0295/2021
|
| PIP number |
EMEA-001171-PIP01-11-M02
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Cardioplegia
|
| Route(s) of administration |
Intracoronary use
|
| Contact for public enquiries |
MIT Gesundheit GmbH
Switzerland |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|